These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7517275)

  • 1. Experience with buccal phentolamine mesylate for impotence.
    Zorgniotti AW
    Int J Impot Res; 1994 Mar; 6(1):37-41. PubMed ID: 7517275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.
    Zorgniotti AW; Lefleur RS
    J Urol; 1985 Jan; 133(1):39-41. PubMed ID: 2578067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injection therapy for impotence.
    Kursh ED; Bodner DR; Resnick MI; Althof SE; Turner L; Risen C; Levine SB
    Urol Clin North Am; 1988 Nov; 15(4):625-9. PubMed ID: 3055615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intracavernous pharmacotherapy.
    Sidi AA
    Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 8. A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction.
    McMahon CG
    Int J Impot Res; 1996 Dec; 8(4):233-6. PubMed ID: 8981173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of impotence with administration of chemical prosthesis using real-time mechanical sector duplex scanner--with special reference to diabetic patients].
    Nakajima Y; Shibayama T; Yamamoto H; Suzuki Y; Matsuoka K; Kaneda S
    Hinyokika Kiyo; 1989 Apr; 35(4):623-30. PubMed ID: 2472055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction.
    Padma-Nathan H; Goldstein I; Klimberg I; Coogan C; Auerbach S; Lammers P;
    Int J Impot Res; 2002 Aug; 14(4):266-70. PubMed ID: 12152116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
    Lin JS; Chang WC; Lui SM
    Proc Natl Sci Counc Repub China B; 1994 Jan; 18(1):12-6. PubMed ID: 8029369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM; Gaston R; Piechaud T; Le Guillou M
    Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic erection program for the treatment of male impotence.
    Trapp JD
    South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study.
    Shamloul R; El-Dakhly M; Ghanem H; Gadallah A; Mokhtar H
    J Sex Med; 2004 Nov; 1(3):310-3. PubMed ID: 16422961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of penile erection by intracavernosal injection: a double-blind comparison of phenoxybenzamine versus papaverine-phentolamine versus saline.
    Szasz G; Stevenson RW; Lee L; Sanders HD
    Arch Sex Behav; 1987 Oct; 16(5):371-8. PubMed ID: 3689105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.